ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,626.76
0.20%
Dow Jones
40,164.35
0.41%
US Dollar vs MXN
17.7858
0.48%
Brent Oil
84.205
-0.46%
Bitcoin
63,354.67
4.23%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Mgi Pharma (MM) (MOGN)

  7. Mgi Pharma (MM) (MOGN) Noticias

MOGN

Mgi Pharma (MM) (MOGN)

Mgi Pharma (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MOGN
FechaHoraFuenteTítuloSímboloCompañía
02/02/200606:00Business WireMGI PHARMA to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices ConferenceNASDAQ:MOGNMgi Pharma (MM)
01/02/200606:00Business WireMGI PHARMA Fourth Quarter and Year End 2005 Financial Results Conference Call to Be Webcast on February 8, 2006NASDAQ:MOGNMgi Pharma (MM)
10/01/200610:25Business WireMGI PHARMA Provides Corporate Update; 2005 Aloxi(R) Injection Sales Increase 56% To Approximately $248 Million; 2006 Sales of AlNASDAQ:MOGNMgi Pharma (MM)
15/12/200515:37PR Newswire (US)Dacogen(TM) (Decitabine) Injection Complete Response Accepted for Review by U.S. FDANASDAQ:MOGNMgi Pharma (MM)
12/12/200508:34PR Newswire (US)Dacogen(TM) (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual MeetingNASDAQ:MOGNMgi Pharma (MM)
22/11/200506:00Business WireMGI PHARMA to Present at the Lazard Capital Markets Life Sciences ConferenceNASDAQ:MOGNMgi Pharma (MM)
15/11/200508:28PR Newswire (US)MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen(TM) (decitabine) Injection for MDSNASDAQ:MOGNMgi Pharma (MM)
15/11/200508:27Business WireMGI PHARMA And SuperGen Provide Regulatory Status Updates For Dacogen(TM) (Decitabine) Injection For MDS; Approvable Letter RespNASDAQ:MOGNMgi Pharma (MM)
20/10/200506:01Business WireMGI PHARMA Announces Commencement of Tender Offer for Guilford Pharmaceutical Notes Due 2008NASDAQ:MOGNMgi Pharma (MM)
19/10/200515:02Business WireMGI PHARMA Reports Third Quarter Financial ResultsNASDAQ:MOGNMgi Pharma (MM)
19/10/200511:45Business WireMGI PHARMA Ranked Among Top Half of Fastest Growing North American Technology Companies on 2005 Deloitte Technology Fast 500; CoNASDAQ:MOGNMgi Pharma (MM)
12/10/200506:00Business WireMGI PHARMA Third Quarter 2005 Financial Results Conference Call to Be Webcast on October 19, 2005NASDAQ:MOGNMgi Pharma (MM)
03/10/200515:00Business WireMGI PHARMA Completes Acquisition of Guilford PharmaceuticalsNASDAQ:MOGNMgi Pharma (MM)
29/09/200517:27PR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:MOGNMgi Pharma (MM)
20/09/200506:00Business WireMGI PHARMA to Present at the UBS 2005 Global Life Sciences ConferenceNASDAQ:MOGNMgi Pharma (MM)
05/09/200506:00Business WireMGI PHARMA to Present at the Bear Stearns 18th Annual Healthcare ConferenceNASDAQ:MOGNMgi Pharma (MM)
02/09/200506:00Business WireMGI PHARMA to Present at the BioCentury NewsMakers in the Biotech Industry ConferenceNASDAQ:MOGNMgi Pharma (MM)
14/07/200510:09PR Newswire (US)MORNING UPDATE: Mankus-Lavelle Group issues alerts for AAPL, ABT, UNH, DRL, and MOGNNASDAQ:MOGNMgi Pharma (MM)
13/07/200515:01Business WireMGI PHARMA Reports Second Quarter ResultsNASDAQ:MOGNMgi Pharma (MM)
06/07/200506:05Business WireMGI PHARMA Second Quarter 2005 Financial Results Conference Call to Be Webcast on July 13, 2005NASDAQ:MOGNMgi Pharma (MM)
01/06/200508:15Business WireMGI PHARMA to Present at the Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:MOGNMgi Pharma (MM)
10/05/200506:00Business WireMGI PHARMA to Present at the 2005 Banc of America Securities Health Care ConferenceNASDAQ:MOGNMgi Pharma (MM)
05/05/200506:00Business WireMGI PHARMA to Present at the Robert W. Baird 2005 Growth Stock ConferenceNASDAQ:MOGNMgi Pharma (MM)
12/01/200509:28PR Newswire (US)MORNING UPDATE: Man Securities Inc. Issues Alerts for TASR, DNDN, X, MOGN, and PDENASDAQ:MOGNMgi Pharma (MM)
03/01/200507:00PR Newswire (US)Dacogen(TM) NDA Accepted for Filing by FDANASDAQ:MOGNMgi Pharma (MM)
01/11/200407:02PR Newswire (US)SuperGen and MGI PHARMA Announce Submission of Dacogen(TM) NDA to U.S. FDANASDAQ:MOGNMgi Pharma (MM)
25/10/200408:02PR Newswire (US)SuperGen and MGI PHARMA Announce Acceptance of Dacogen(TM) MAA for Review by EMEANASDAQ:MOGNMgi Pharma (MM)
01/10/200409:49PR Newswire (US)/C O R R E C T I O N -- SuperGen, Inc.; MGI PHARMA, INC./NASDAQ:MOGN
01/10/200409:18PR Newswire (US)SuperGen and MGI PHARMA Announce Filing of MAA for Approval of Dacogen(TM) in EuropeNASDAQ:MOGNMgi Pharma (MM)
22/09/200407:00PR Newswire (US)MGI PHARMA and SuperGen Announce Closing of Stock Purchase Agreement and Effectiveness of License AgreementNASDAQ:MOGNMgi Pharma (MM)
 Showing the most relevant articles for your search:NASDAQ:MOGN

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
CCOM
US30
US 30
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
FX
EURUSD
Euro vs US Dollar
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados